96736 ⎘
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Linear peptides containing only normal peptide links having 5 to 11 amino acids
Polypeptides having anti-senescent effects and uses thereof
#302HEXAPEPTIDE,COSMETIC COMPOSITION OR PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE OF HEXAPEPTIDE
#303IL-17F AND IL-17A-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING
#304CELL-PENETRATING PEPTIDE, ANTI-CANCER PEPTIDE, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING SAME
#305Peptide compounds targeting PD-1 receptor as well as preparation and applications thereof
#306PRE-TARGETING STRATEGIES FOR MOLECULAR IMAGING AND/OR RADIOIMMUNOTHERAPY
#307DELIVERY OF CAS9 VIA ARRDC1-MEDIATED MICROVESICLES (ARMMS)
#308PEPTIDE FRAGMENTS FOR TREATMENT OF DIABETES
#309COMPOUND FOR THE SEQUESTRATION OF UNDESIRABLE ANTIBODIES IN A PATIENT
#310COLD ATMOPSHERIC PLASMA TREATED PAN-CANCER EPITOPE PEPTIDE WITHIN THE COLLAGEN TYPE VI A-3 (COL6A3) PROTEIN AS CANCER VACCINE
#311POST-PROCESSING OF BIOLOGICAL SCAFFOLDS
#312CELL PENETRATING PEPTIDE
#313PYRAZOLE AND PYRAZOLINE-CONTAINING PEPTIDES, HIGH THROUGHPUT CLICK LIBRARIES, AND METHODS
#314NLRP3 INFLAMMASOME INHIBITORY PEPTIDE FOR TREATMENT OF INFLAMMATORY DISEASES
#315LEPTIN RECEPTOR AFFINITY PEPTIDE AND USE THEREOF
#316COMPOSITIONS COMPRISING HYDROXYETHYL-CAPPED CATIONIC PEPTOIDS
#317MICROPEPTIDES AND USE OF SAME FOR MODULATING GENE EXPRESSION
#318PLASMIN-RESISTANT PEPTIDES FOR IMPROVED THERAPEUTIC INDEX
#319NOVEL PEPTIDES AND USES THEREOF FOR TREATING CANCER
#320PEPTIDE-CONTAINING COMPOSITION
#321DIMERIZATION STRATEGIES AND COMPOUNDS FOR MOLECULAR IMAGING AND/OR RADIOIMMUNOTHERAPY
#322Antimicrobial Peptides and Their Use
#323DEOXYCHOLIC ACID-PEPTIDE CONJUGATE HAVING ANTI-OBESITY ACTIVITY AND USE THEREOF
#324NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#325ANALGESIC AND ANESTHETIC PEPTIDES AND OTHER AGENTS
#326Immune checkpoint inhibitor combinations
#327PEPTIDE HAVING ACTIVITY OF PREVENTING HAIR LOSS OR PROMOTING HAIR GROWTH, AND USE THEREOF
#328PEPTIDE, COMPOSITION, AND GHRELIN SECRETION PROMOTING AGENT
#329PEPTIDE EXHIBITING BOTULINUM TOXIN-LIKE ACTIVITY, AND USE THEREOF
#330NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CLL AND OTHER CANCERS
#331PROTEIN-DERIVED PEPTIDE FOR IMPROVING IMMUNITY AGAINST 2019 NOVEL CORONAVIRUS (2019-nCoV) AND USE THEREOF
#332NMU RECEPTOR 2 AGONISTS
#333ANTI-HEPATITIS B VIRUS AGENT TARGETING HOST FACTOR LIPG
#334LEADER PEPTIDES AND POLYNUCLEOTIDES ENCODING THE SAME
#335SHORT ANTIMICROBIAL PEPTIDES
#336ANTIMICROBIAL PEPTIDES
#337ANTIGENIC TRIPEPTIDES DERIVED FROM MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS S-TYPE STRAINS, DERIVATIVES AND USES THEREOF
#338Dry powder formulation of caveolin-1 peptides and methods of use thereof
#339ANTIMICROBIAL PEPTIDE (AMP) FOR CONTROLLING PSEUDOMONAS SYRINGAE PV. ACTINIDIAE (PSA) AND PREPARATION METHOD AND USE THEREOF
#340CPMV BINDING PEPTIDE
#341RHFGF21 FUSION PROTEIN, POLYNUCLEOTIDE ENCODING RHFGF21 FUSION PROTEIN, COMPOSITION CONTAINING RHFGF21 FUSION PROTEIN, AND USE OF RHFGF21 FUSION PROTEIN
#342COMPOSITIONS AND METHODS FOR INHIBITING AN INFLAMMATORY RESPONSE AND TREATING INFLAMMATORY DISEASES
#343PEPTIDE DRUG CONJUGATES SPECIFIC TO FIBRONECTIN ISOTYPES FOR CANCER THERAPY
#344THIOREDOXIN 1 EPITOPE AND MONOCLONAL ANTIBODY SPECIFICALLY BINDING THERETO
#345GLP1/GIP/NPY2 RECEPTOR TRIPLE AGONISTS
#346TARGETED DELIVERY OF TERTIARY AMINE-CONTAINING DRUG SUBSTANCES
#347PEPTIDE LIQUID DROPLETS AND METHODS OF USING THE SAME
#348MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE OR CYSTEINE PROTEASE-CLEAVABLE SUBSTRATES AND METHODS OF USE THEREOF
#349PEPTIDE AND METHOD FOR TREATING PAIN USING THE SAME
#350SINGLE-DOMAIN ANTIGEN-DEPENDENT ANTIBODY-LIKE FUSION PROTEINS
#351COMPOSITIONS INCLUDING CONJUGATED THERAPY ENHANCERS
#352TEMPORAL TRAUMATIC BRAIN INJURY BIOMARKERS AND METHODS OF USE THEREOF
#353MODIFIED ANTIBODY COMPOSITIONS, METHODS OF MAKING AND USING THEREOF
#354Novel Peptide Compound Or Pharmaceutically Acceptable Salt Thereof
#355GLUCOSAMINE DERIVATIVE NANOPARTICLE AND PREPARATING METHOD AND USE THEREOF
#356PROTEIN-BASED THERAPIES FOR OCULAR CONDITIONS
#357PEPTIDE AMPHIPHILES WITH MODIFIED DEGRADING SEQUENCES AND METHODS OF USE THEREOF
#358PEPTIDES AND THEIR USE IN THE TREATMENT OF INFLAMMATION
#359PEPTIDE-FC FUSIONS FOR TREATING AMYLOID DISORDERS
#360A4B7 THIOETHER PEPTIDE DIMER ANTAGONISTS
#361COMPOSITIONS AND METHODS FOR MODULATING GAMMA-C-CYTOKINE ACTIVITY
#362PEPTIDE COMPOUND, APPLICATION THEREOF AND COMPOSITION CONTAINING SAME
#363NOVEL PEPTIDE HAVING ANTI-INFLAMMATORY AND TISSUE REGENERATIVE ACTIONS
#364PEPTIDES COMPRISING A PHOSPHORYLCHOLINE CONJUGATE AND METHODS OF SYNTHESIZING SAME
#365METHODS AND COMPOSITIONS COMPRISING MHC CLASS I PEPTIDES
#366CARGO MOLECULE TRANSDUCTION DOMAIN RMAD1, VARIANT THEREOF, RECOMBINANT CARGO MOLECULE, AND METHOD FOR TRANSDUCING CARGO MOLECULE USING SAME
#367Compositions and method of use for hair straightening and shaping
#368Zinc-charged peptides for the treatment of cancer and alzheimer's disease
#369OLIGOPEPTIDE
#370HEPTAPEPTIDE AMIDES FOR USE IN THE TREATMENT OF HMGB1-DEPENDENT DISEASES
#371POLYPEPTIDE HAVING MMP2-INHIBITORY EFFECT
#372SUBSTITUTION OF HISTIDINE WITH 2-THIOHISTIDINE IN BIOACTIVE PEPTIDES
#373THIOREDOXIN 1 EPITOPE AND MONOCLONAL ANTIBODY SPECIFICALLY BINDING THERETO
#374PEPTIDE COMPOUNDS AND THERAPEUTIC USES OF SAME
#375FIBRIL PEPTIDES
#376Peptides and methods for reducing skin pigmentation
#377NOVEL PEPTIDE
#378PEPTIDES FOR THE TREATMENT OF CANCER
#379METHOD OF TREATING MELANOCORTIN-4 RECEPTOR-ASSOCIATED DISORDERS IN HETEROZYGOUS CARRIERS
#380KEAP1/NRF2 PROTEIN-LIKE POLYMERS
#381IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING LUNG CANCER
#382NEW PEPTIDE-BASED DIAGNOSTIC AND THERAPEUTIC AGENTS
#383MELANOCORTIN RECEPTOR LIGANDS MODIFIED WITH HYDANTOIN
#384TRANSPORTER PEPTIDES AND APPLICATION THEREOF
#385PEPTIDE LIBRARIES WITH NON-CANONICAL AMINO ACIDS
#386CYCLIC PEPTIDYL INHIBITORS OF CAL-PDZ BINDING DOMAIN
#387PEPTIDE-COMPOUND CYCLIZATION METHOD
#388REGULATORY T CELL-INDUCING PEPTIDE AND COMPOSITION INCLUDING SAME FOR PREVENTING OR TREATING AUTOIMMUNE DISEASE
#389THERAPEUTIC PEPTIDES
#390NEW PEPTIDE CONJUGATES
#391MULTIVALENT PEPTOID OLIGOMERS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING SAME
#392MULTIFUNCTIONAL POLYPEPTIDE AND APPLICATION THEREOF IN FIELD OF MEDICINES
#393BRANCHED PEPTIDES FOR ENZYMATIC ASSEMBLY AND MITOCHONDRIA DRUG DELIVERY
#394PEPTIDE AND COMPOSITION CONTAINING PEPTIDE AS ACTIVE INGREDIENT
#395INHIBITORS OF ANTIGEN PRESENTATION BY MHC CLASS II HLA-DRB1*15:01 MOLECULES WITH ENHANCED METABOLIC STABILITY
#396POLYPEPTIDE COMPOUND AND APPLICATION THEREOF
#397METHOD OF FORMING PEPTIDE-COATED NANOPARTICLES
#398FLAVIVIRUS PEPTIDE SEQUENCES, EPITOPES, AND METHODS AND USES THEREOF
#399MATRIX METALLOPROTEINASE SUBSTRATES AND OTHER CLEAVABLE MOIETIES AND METHODS OF USE THEREOF
#400MATRIPTASE AND U-PLASMINOGEN ACTIVATOR SUBSTRATES AND OTHER CLEAVABLE MOIETIES AND METHODS OF USE THEREOF
#401INSECT NEUROPEPTIDES 7
#402Insect neuropeptides 6
#403PROBIOTIC MOLECULES FOR REDUCING PATHOGEN VIRULENCE
#404PEPTIDES AND CONJUGATES THEREOF AS ACE-2 AND S1 SUBUNIT MIMICS AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 (SARS-COV2) INFECTION
#405Targeted delivery system and methods of use therefor
#406PLATINUM/PEPTIDE/CUCURBITURIL COMPLESES: WELL-DEFINED ARCHITECTURES BUILT BY SUPRAMOLECULAR SELF-SORTING FOR THE TARGETING OF CYSTEINE PROTEASES
#407TEMPORAL TRAUMATIC BRAIN INJURY BIOMARKERS AND METHODS OF USE THEREOF
#408TREATMENTS FOR DISEASES AND DISORDERS THAT INVOLVE OXIDATIVE STRESS
#409Compositions that target tumor-associated macrophages and methods of use therefor
#410PROTEIN-BASED THERAPIES FOR OCULAR CONDITIONS
#411Modulation of Wnt5a to Treat Glaucoma
#412NEW PEPTIDES
#413Peptides and combination of peptides for use in immunotherapy against non-small cell lung cancer and other cancers
#414COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES AND USES THEREOF
#415MODIFIED PEPTIDES FOR THE INHIBITION OF ABNORMAL TAU ACCUMULATION
#416THERAPEUTIC AGENTS FOR REDUCING PARATHYROID HORMONE LEVELS
#417COMPOSITIONS AND METHODS FOR TARGETED ANTIFIBROTIC THERAPY IN CHRONIC PANCREATITIS
#418TISSUE OCCLUDING AGENT COMPRISING AN IEIKIEIKIEIKI PEPTIDE
#419BINDING PEPTIDES AND USES THEREOF
#420THERAPEUTIC COMPOSITIONS INCLUDING SPN10 AND USES THEREOF
#421Anti-PVRIG antibodies and methods of use
#422EPHA2 T-CELL EPITOPE AGONISTS AND USES THEREFORE
#423IMMUNOMODULATORY PEPTIDE
#424ANTIBACTERIAL PEPTIDES AND COMPOUNDS TARGETING TOXIN-ANTITOXIN SYSTEM OF KLEBSIELLA PNEUMONIAE, AND THEIR USE
#425ANTIMICROBIAL PEPTIDES AND METHOD OF PREVENTING OR TREATING INFECTION BY USING THE SAME
#426BI-TERMINAL PEGYLATED INTEGRIN-BINDING PEPTIDES AND METHODS OF USE THEREOF
#427FIBROBLAST GROWTH FACTOR RECEPTOR (FGFR)-TARGETING ANTAGONISTIC SHORT PEPTIDE
#428COMPOSITIONS AND METHODS FOR CANCER IMAGING AND RADIOTHERAPY
#429ADENO-ASSOCIATED VIRAL VECTOR VARIANTS
#430PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST NON-SMALL CELL LUNG CANCER AND OTHER CANCERS
#431NOVEL PEPTIDES CAPABLE OF ALTERING NK CELL ACTIVITY
#432INHIBITION OF DEGRANULATION OF NEUTROPHIL CELLS IN COVID-19 PATIENTS
#433PREPARATION OF FUNCTIONAL HOMOCYSTEINE RESIDUES IN POLYPEPTIDES AND PEPTIDES
#434Compositions and methods of treating ocular diseases
#435A SENSITIZER- PEPTIDE CONJUGATE
#436FORMULATIONS AND METHODS FOR MHC-I RESTRICTED EPITOPE IMMUNIZATION
#437POLYMER COMPOUND COMPRISING PENDENT PEPTIDES, METHOD FOR PREPARING SAME AND USES THEREOF
#438MATRIX METALLOPROTEINASE SUBSTRATES AND OTHER CLEAVABLE MOIETIES AND METHODS OF USE THEREOF
#439Desmoglein 2 (DSG2) Binding Proteins and Uses Therefor
#440Nucleic acids encoding peptides that block binding of a2d-1 to glutamate receptors for treating diseases and disorders
#441MODIFIED PEPTIDES AND ASSOCIATED METHODS OF USE
#442PEPTIDES, COMBINATION OF PEPTIDES, AND CELL BASED MEDICAMENTS FOR USE IN IMMUNOTHERAPY AGAINST URINARY BLADDER CANCER AND OTHER CANCERS
#443VIRAL VECTOR FOR THE TARGETED TRANSFER OF GENES IN THE BRAIN AND SPINAL CORD
#444INHIBITORS OF NF KAPPA-B ACTIVITY FOR TREATMENT OF DISEASES AND DISORDERS
#445Modified peptide ligands for stable delivery of highly potent payloads to tumors: Method of making and using same
#446Composition Comprising an Antiviral Agent and a CXCR4 Selective Antagonist and Methods For Using the Same
#447POLYPEPTIDES RV3 AND RV4 HAVING ANTI-AGING FUNCTION AND APPLICATIONS THEREOF
#448IMMUNOGENIC PRODUCTS BASED ON MUTEIN AMYLOID beta (Abeta) AMINO ACID SEQUENCES AND USES THEREOF
#449Interference Peptides As Inhibitors Of Interactions Related To Ampar Endocytosis
#450POLYPEPTIDE HAVING ANTI-AGING ACTIVITY, AND APPLICATION THEREOF
#451Inhibition of pulmonary fibrosis with nutlin-3A and peptides
#452MEDICAL DEVICE, AND HYDROGEL, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
#453SAP AND PEPTIDOMIMETIC COMPOSITIONS FOR REDUCING SYMPTOMS OF INFLAMMATION
#454ANTIBACTERIAL AGENTS
#455RECOMBINANT MICROALGAE ABLE TO PRODUCE KTTKS PEPTIDES, POLYPEPTIDES, OR PROTEINS AND THEIR DERIVATIVES AND ASSOCIATED METHOD AND USES THEREOF
#456COMPOSITIONS TARGETING TUMOR ASSOCIATED MACROPHAGES AND METHODS USING SAME
#457CD200 INHIBITORS AND METHODS OF USE THEREOF
#458IMMUNOSTIMULATORY METHOD
#459PEPTIDE CONJUGATES
#460NOOTROPIC PEPTIDES FOR TREATING LYSOSOMAL STORAGE DISEASES
#461LINKED AND OTHER pH-TRIGGERED COMPOUNDS
#462ORAL OCTREOTIDE ADMINISTERED IN COMBINATION WITH OTHER THERAPEUTIC AGENTS
#463POLYPEPTIDE FOR PREVENTING OR TREATING IDIOPATHIC PULMONARY FIBROSIS AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
#464CASTRATION RESISTANT PROSTATE CANCER
#465PEPTIDES FOR PREVENTING OR TREATING HEART AND BLOOD VESSEL DISEASES
#466PVRIG POLYPEPTIDES AND METHODS OF TREATMENT
#467Integrin binding peptides and uses thereof
#468ADHESIVE PEPTIDES
#469AMIDATED PEPTIDES AND THEIR DEAMIDATED COUNTERPARTS DISPLAYED BY HLA-A*02 FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS
#470MODIFIED PEPTIDE FRAGMENTS OF CAV-1 PROTEIN AND THE USE THEREOF IN THE TREATMENT OF FIBROSIS
#471PEPTIDE DISINFECTANT FOR PREVENTING CORONAVIRUSES
#472ANTINOCICEPTIVE COMPOUNDS AND USES THEREOF
#473METHOD OF TREATMENT OF IRRITABLE BOWEL SYNDROME
#474METHODS AND MATERIALS FOR TREATING CANCER
#475PEPTIDE TAG AND TAGGED PROTEIN CONTAINING SAME
#476PPEPTIDE HAVING PROTECTIVE ACTIVITY AGAINST CELL DAMAGE CAUSED BY PARTICULATE MATTER, AND USES FOR SAME
#477WAFER LEVEL CHIP SCALE PACKAGE WITH RHOMBUS SHAPE
#478COMPOUNDS AND PHARMACEUTICAL USE THEREOF IN THE TREATMENT OF CANCER
#479METHODS FOR TREATING INFLAMMATION USING ANTIBODIES TO KALLIDIN AND DES-ARG10-KALLIDIN
#480IMMUNOGLOBULIN PURIFICATION PEPTIDES AND THEIR USE
#481ENHANCED SKIN PERMEATION OF A NOVEL PEPTIDE VIA STRUCTURAL MODIFICATION, CHEMICAL ENHANCEMENT, AND MICRONEEDLES
#482Imaging systems and methods
#483NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS
#484COMPOSITIONS FOR INDUCING URINARY VOIDING AND DEFECATION
#485AMYLOID-beta AGGREGATION INHIBITOR, PHARMACEUTICAL COMPOSITION FORAMYLOID-beta AGGREGATION DISEASE, AND USE APPLICATION OF SAME
#486Peptide-based Dopa containing adhesive gels
#487Angiotensin i-converting enzyme (ACE) inhibitory peptides
#488Compositions and method for optimized peptide vaccines using residue optimization
#489ß-AMYLOID VACCINE FOR THE TREATMENT OF ALZHEIMER’S DISEASE
#490HELICAL STAPLED PEPTIDES AND USES THEREOF
#491DISCOVERY OF YEATS2 YEATS DOMAIN INHIBITORS AS NOVEL ANTI-CANCER AGENTS
#492COMPOSITION FOR IMPROVING HAIR HEALTH
#493NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#494CONJUGATES OF MONTELUKAST AND PEPTIDES
#495Method and compositions for creating magnetically aligned, bioactive scaffolds for tissue regeneration
#496ADENO-ASSOCIATED VIRAL VECTOR VARIANTS
#497PROTEOGLYCAN MIMETICS FOR ENHANCED WOUND HEALING, ANGIOGENESIS, AND VASCULAR REPAIR
#498Peptides
#499PEPTIDES AND COMBINATION THEREOF FOR USE IN THE IMMUNOTHERAPY AGAINST CANCERS
#500NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS
#501Treatments for Gastrointestinal Disorders
#502NOVEL PEPTIDE, COMPOSITIONS AND METHOD FOR DELIVERY OF AGENTS INTO CELLS AND TISSUES
#503Methods and compositions for visualizing a ureter in a surgical procedure
#504NOVEL PEPTIDE-BASED CANCER IMAGING AGENTS
#505NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS
#506PHAGE-PEPTIDE CONSTRUCTS FOR STIMULATION OF AN ANTI-CANCER IMMUNE RESPONSE AGAINST CD47
#507MIRAC PROTEINS
#508NEW MULTI-FUNCTIONAL OLIGOPEPTIDES
#509BISPECIFIC FUSION POLYPEPTIDE COMPOUND
#510AN IMPROVED PROCESS FOR FMOC SYNTHESIS OF ETELCALCETIDE
#511NOVEL PEPTOID COMPOUNDS THAT BIND TO CELL RECEPTOR ACE2 AND PREVENT VIRUS ENTRY INTO CELLS
#512RECOMBINANT PROTEIN COMPRISING MULTIPLE MULTI-PEPTIDE SETS, PHARMACEUTICAL COMPOSITION COMPRISING THE RECOMBINANT PROTEIN, AND METHOD FOR PREPARING THE RECOMBINANT PROTEIN
#513RECOMBINANT PROTEIN COMPRISING MULTIPLE MULTI-PEPTIDE SETS, PHARMACEUTICAL COMPOSITION COMPRISING THE RECOMBINANT PROTEIN, AND METHOD FOR PREPARING THE RECOMBINANT PROTEIN
#514Anti-allergic peptide and use thereof for immune regulation and anti-allergy
#515HUNTINGTIN-RELATED PEPTIDE AGENTS AND USES THEREOF
#516NOVEL PEPTIDES AND USES THEREOF
#517PEPTIDES AND PHARMACEUTICAL COMPOSITIONS FOR TREATING EYE DISEASES
#518ANTIBACTERIAL PEPTIDES
#519SELF-ASSEMBLING PEPTIDES, PREPARATION METHODS, SELF-ASSEMBLING PEPTIDE FORMULATIONS AND USE
#520Peptide oligonucleotide conjugates
#521BIOACTIVE PEPTIDES HAVING DETRIMENTAL EFFECTS ON PEST SLUGS
#522CLAUDIN-18.2-SPECIFIC IMMUNORECEPTORS AND T CELL EPITOPES
#523TARGETING PEPTIDES FOR DIRECTING ADENO-ASSOCIATED VIRUSES (AAVs)
#524POLYPEPTIDE FOR REPAIRING MUCOSAL DAMAGE OR SKIN WOUND AND USE THEREOF
#525Solution phase routes for WNT hexapeptides
#526Short Proline Rich Lipopeptide Potentiates Minocycline and Rifampicin Against Multidrug- and Extensively Drug-Resistant Pseudomonas Aeruginosa
#527TRANSMEMBRANE BETA BARREL PROTEINS
#528PEPTIDE SELECTIVELY BINDING TO CANCER CELL-DERIVED EXOSOME, AND USES THEREOF
#529SARS-COV-2 SERUM ANTIBODY PROFILING
#530NOVEL PEPTIDE TAG
#531Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#532CHIMERIC POLYPEPTIDES AND USES THEREOF
#533METHODS FOR ASSEMBLING PEPTIDES INTO PEPTIDE AMPHIPHILE NANOFIBERS
#534NOVEL ANTIBACTERIAL PEPTIDE AND USE THEREOF
#535Saposin-A derived peptides and uses thereof
#536PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS
#537PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS
#538PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS
#539NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS
#540METHOD FOR RAPID IN VITRO SYNTHESIS OF GLYCOPROTEINS VIA RECOMBINANT PRODUCTION OF N-GLYCOSYLATED PROTEINS IN PROKARYOTIC CELL LYSATES
#541AIR-LOADED GAS VESICLE NANOPARTICLES FOR PROMOTING CELL GROWTH IN 3D BIOPRINTED TISSUE CONSTRUCTS
#542FORMULATION OF MODIFIED INTERLEUKIN-7 FUSION PROTEIN
#543NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS
#544Methods and systems for solid phase peptide synthesis
#545TELOMERASE POLYPEPTIDE VACCINE FOR TREATING CANCER
#546Compositions and methods for reducing ice crystal formation
#547PEPTIDOMIMETICS AND METHOD OF SYNTHESIS THEREOF
#548RAMP TAG FOR INSULIN OVEREXPRESSION AND METHOD FOR MANUFACTURING INSULIN USING SAME
#549FUSION PROTEIN AND USE THEREOF
#550NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#551PERSONALIZED IMMUNOTHERAPY AGAINST SEVERAL NEURONAL AND BRAIN TUMORS
#552PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS
#553REAGENT FOR MEASURING SKIN SENSITIZATION, COMPOUND, AND METHOD FOR MEASURING SKIN SENSITIZATION
#554CBX8 chromdomain inhibitors and the uses thereof
#555COMPOUNDS FOR DRUG DELIVERY ACROSS BLOOD-BRAIN BARRIER
#556PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING A PERIODONTAL DISEASE OR DISLOCATED TRAUMATIC TOOTH
#557ALBUMIN BINDING PEPTIDE CONJUGATES AND METHODS THEREOF
#558IMMUNOGENIC PEPTIDES SPECIFIC TO BCMA AND TACI ANTIGENS FOR TREATMENT OF CANCER
#559Cell-penetrating peptides and composition including the same
#560B*44 restricted peptides for use in immunotherapy against cancers and related methods
#561PROTEOGENOMIC-BASED METHOD FOR IDENTIFYING TUMOR-SPECIFIC ANTIGENS
#562NOVEL ALPHA-HELICAL DOUBLE-SIDED CELL PENETRATING PEPTIDE AND USE THEREOF
#563SYNTHESIS OF A GUANYLATE CYCLASE AGONIST BY FRAGMENTS BASED APPROACH
#564a-CARBONYL ALKENYL ESTER PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#565PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS
#566PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS
#567PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS
#568PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS
#569Immunotherapy against neuronal and brain tumors
#570PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS
#571PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS
#572PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS
#573NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS
#574NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS
#575PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#576PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#577PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#578INHIBITORS OF CORONAVIRUS PROTEASE
#579HYDROGEL COMPOSITION AND ASSOCIATED METHOD OF USE
#580PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS
#581ANTI-VIRAL COATING COMPOSITION, AND METHOD FOR FIXING ANTI-VIRAL FUSION PROTEIN TO SURFACES
#582RECEPTORS PROVIDING TARGETED COSTIMULATION FOR ADOPTIVE CELL THERAPY
#583NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS
#584POLYPEPTIDE EXPRESSED IN THE STRATUM CORNEUM AND USE THEREOF
#585Peptide having cytoprotective effect against environmental pollutant and use thereof
#586NANOPARTICLE-LIKE DELIVERY SYSTEM
#587A*03 RESTRICTED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS AND RELATED METHODS
#588CCR8 peptide and T cells for use in immunotherapeutic treatment of various cancers
#589ANG (1-7) DERVIATIVE OLIGOPEPTIDES FOR THE TREATMENT OF PAIN
#590PROBIOTIC BACTERIAL MOLECULES AND THEIR USE IN METHODS TO TREAT/PREVENT INFECTION BY HARMFUL BACTERIA AND TO PROVIDE NUTRITIONAL HEALTH
#591BROAD-SPECTRUM ANTIVIRAL PEPTIDES
#592REGENTIDE-034 AND COMPOSITION FOR IMPROVING CONDITION OF SKIN, CONTAINING SAME
#593S100A8-INHIBITING PEPTIDE AND DISEASE THERAPEUTIC AGENT CONTAINING SAME
#594POLYPEPTIDE TAG AND APPLICATION THEREOF IN IN VITRO PROTEIN SYNTHESIS
#595Compositions and methods of targeting cancer stem cells
#596Modified peptide fragments of CAV-1 protein and the use thereof in the treatment of fibrosis
#597COMPOSITION FOR ANTI-DIABETES AND ANTI-OBESITY COMPRISING NOVEL COMPOUND
#598RADIOTHERAPEUTIC AND COMPANION IMAGING AGENTS TO TARGET MC1R
#599COMPOSITION COMPRISING REGENTIDE-034 AND REGENTIDE-041 FOR SKIN CARE OR WRINKLE REDUCTION
#600Neutrophil-binding peptides